SCHEMBL18565012

SCHEMBL18565012

Cn1c2cc(N(c3ccccc3)c3ccc4ccccc4c3)ccc2c2c3ccccc3ccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO2 P16083 1/20 0.35
▸ KDM4E B2RXH2 4/20 0.34
▸ TOP2A P11388 2/20 0.33
▸ HPGD P15428 3/20 0.33
▸ HSD17B10 Q99714 3/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ ATM Q13315 2/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ CASP7 P55210 1/20 0.33
▸ HIF1A Q16665 1/20 0.33
▸ PER2 O15055 1/20 0.32
▸ CRY1 Q16526 1/20 0.32
▸ CRY2 Q49AN0 1/20 0.32
▸ PABPC1 P11940 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18564817 0.96 NQO2 (0.37) NQO2KDM4ETOP2AHPGDHSD17B10
SCHEMBL13507561 0.95 NQO2 (0.33) NQO2KDM4ETOP2AHPGDHSD17B10
SCHEMBL18565011 0.93 RXRA (0.39) NQO2L3MBTL1RAB9APER2CRY1
SCHEMBL18565009 0.93 RXRA (0.39) NQO2L3MBTL1RAB9APER2CRY1
SCHEMBL18564828 0.91 MAOB (0.37) NQO2TOP2AHPGDHSD17B10L3MBTL1
SCHEMBL18565032 0.91 KDM4E (0.35) NQO2KDM4EHPGDHSD17B10L3MBTL1
SCHEMBL13506985 0.91 NQO2 (0.35) NQO2KDM4ETOP2AHPGDHSD17B10
SCHEMBL18564929 0.89 MAOB (0.36) NQO2TOP2AHPGDHSD17B10L3MBTL1
SCHEMBL13507586 0.88 HTR1D (0.36) —
SCHEMBL18564747 0.87 RXRA (0.41) NQO2KDM4EHPGDHSD17B10L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-05-14 — — US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 — — US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device EED, BMI1, CD99 NQO2 4146/4885KDM4E 225/4885TOP2A 4236/4885
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 NQO2 4146/4885KDM4E 225/4885TOP2A 4236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback